Total Funding
63
69
Total FundingGrant raised
Growth Score 63 in past quarter
-6 pts
Heat Score 69 in past quarter
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
169456
BioBlocks is a medicinal research organization that provides medicinal chemistry services and products to pharmaceutical customers.
Acquired by 

Genesis Biotechnology Group
- Peter Pallai: Founder, President and Chief Executive Officer

Genesis Biotechnology Group
About the Company
BioBlocks is a collaborative medicinal chemistry research organization focused on drug discovery from initial lead discovery through identification of development candidates. They believe that collaboration empowers scientists to achieve more than any single entity or individual could alone. They join forces with their clients to discover compounds
qualified for advancement to phase two clinical trials.